MedPath

HYPAQUE SODIUM LIQ 50%

HYPAQUE SODIUM LIQ 50%

Discontinued
DIN Number

02017784

Drug Class

Human

Market Date

Dec 31, 1954

Company
HC

sanofi canada, inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02017784
AIG Number0101806001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
V08AA01 DIATRIZOIC ACID
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DIATRIZOATE SODIUMActive
Strength: 50 %
Monograph: DIATRIZOATE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.